Vyome BioSciences, of New Delhi, India, named Richard Buchta, previously head of Glaxosmithkline plc's dermatology unit Stiefel Laboratories in Australia, senior vice-president of research and development. Vyome also added Ranjan Pai, CEO of the Manipal Education & Medical Group International India Pvt. Ltd., of Bengaluru, to its board.